TY - JOUR
T1 - M3NetFlow
T2 - A multi-scale multi-hop graph AI model for integrative multi-omic data analysis
AU - Zhang, Heming
AU - Goedegebuure, S. Peter
AU - Ding, Li
AU - DeNardo, David
AU - Fields, Ryan
AU - Province, Michael
AU - Chen, Yixin
AU - Payne, Philip
AU - Li, Fuhai
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025/3/21
Y1 - 2025/3/21
N2 - Multi-omic data-driven studies are at the forefront of precision medicine by characterizing complex disease signaling systems across multiple views and levels. The integration and interpretation of multi-omic data are critical for identifying disease targets and deciphering disease signaling pathways. However, it remains an open problem due to the complex signaling interactions among many proteins. Herein, we propose a multi-scale multi-hop multi-omic network flow model, M3NetFlow, to facilitate both hypothesis-guided and generic multi-omic data analysis tasks. We evaluated M3NetFlow using two independent case studies: (1) uncovering mechanisms of synergy of drug combinations (hypothesis/anchor-target guided multi-omic analysis) and (2) identifying biomarkers of Alzheimer's disease (generic multi-omic analysis). The evaluation and comparison results showed that M3NetFlow achieved the best prediction accuracy and identified a set of drug combination synergy- and disease-associated targets. The model can be directly applied to other multi-omic data-driven studies.
AB - Multi-omic data-driven studies are at the forefront of precision medicine by characterizing complex disease signaling systems across multiple views and levels. The integration and interpretation of multi-omic data are critical for identifying disease targets and deciphering disease signaling pathways. However, it remains an open problem due to the complex signaling interactions among many proteins. Herein, we propose a multi-scale multi-hop multi-omic network flow model, M3NetFlow, to facilitate both hypothesis-guided and generic multi-omic data analysis tasks. We evaluated M3NetFlow using two independent case studies: (1) uncovering mechanisms of synergy of drug combinations (hypothesis/anchor-target guided multi-omic analysis) and (2) identifying biomarkers of Alzheimer's disease (generic multi-omic analysis). The evaluation and comparison results showed that M3NetFlow achieved the best prediction accuracy and identified a set of drug combination synergy- and disease-associated targets. The model can be directly applied to other multi-omic data-driven studies.
KW - Biocomputational method
KW - Complex systems
KW - Omics
UR - http://www.scopus.com/inward/record.url?scp=85217918093&partnerID=8YFLogxK
U2 - 10.1016/j.isci.2025.111920
DO - 10.1016/j.isci.2025.111920
M3 - Article
C2 - 40034855
AN - SCOPUS:85217918093
SN - 2589-0042
VL - 28
JO - iScience
JF - iScience
IS - 3
M1 - 111920
ER -